AtriCure (ATRC) vs Kestra Medical Technologies (KMTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
AtriCure (ATRC) has outperformed Kestra Medical Technologies (KMTS) over the past year, gaining 56.2% versus a gain of 7.4%. AtriCure is the larger company by market cap ($2.69 billion vs $1.53 billion), about 1.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATRC | KMTS |
|---|---|---|
| Share price | $52.84 | $25.77 |
| Market cap | $2.69B | $1.53B |
| 1-day change | -0.88% | -2.72% |
| YTD return | +34.76% | -2.83% |
| 1-year return | +56.24% | +7.37% |
| 5-year return | -25.30% | — |
| P/E ratio (TTM) | 251.62 | — |
| Forward P/E | 121.76 | — |
| EPS (TTM) | $0.21 | $-2.67 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $534.53M | — |
| Revenue growth (YoY) | +14.88% | — |
| Net income (latest FY) | $-11.45M | — |
| Gross margin | 74.98% | — |
| Operating margin | -1.77% | — |
| Net margin | -2.14% | — |
| 52-week high | $61.70 | $30.00 |
| 52-week low | $25.36 | $17.34 |
| Distance from 52-week high | -14.36% | -14.10% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +3.88% | +17.54% |
| Average volume | 1.09M | 357.97K |
| Shares outstanding | 50.87M | 59.56M |
| Employees | 1,350 | 443 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ATRC has outperformed KMTS by 48.9 percentage points over the past year.
About AtriCure
ATRC stock →AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.
Health Care · Medical/Dental Instruments · 1,350 employees
About Kestra Medical Technologies
KMTS stock →Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.
Health Care · Medical/Dental Instruments · 443 employees
ATRC vs KMTS FAQ
Which is bigger, AtriCure or Kestra Medical Technologies?
AtriCure (ATRC) is larger, with a market capitalization of $2.69B compared with $1.53B for Kestra Medical Technologies (KMTS).
Which stock has performed better over the past year, ATRC or KMTS?
ATRC returned +56.24% over the past 12 months, compared with +7.37% for KMTS (price return, excluding dividends). Past performance does not predict future results.
Are AtriCure and Kestra Medical Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.